This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Anglo American resumes operations at Minas-Rio iron ore mine in Brazil after inspecting pipeline carrying ore from mine to port, and replacing 4km section. 2019 production expected 16-19m tonnes, with underlying 2018 EBITDA loss of $320m, towards bottom end of $300-400m guidance.
Interserve agrees to debt-for-equity swap; “material dilution” for existing shareholders; portion of new equity will be offered to existing shareholders and new investors through public offering. Plan will reduce net debt below 1.5x EBITDA by end-19. Thinking of spinning off RMD Kwikform unit to new entity controlled by creditors. Agreed to defer debt payment to 30 Apr (from 1 Feb).
Banks may be sensitive to US bank regulators warn of ‘living will’ shortcomings at Barclays, Credit Suisse, Deutsche and UBS.
After poor 38% uptake of Kier’s 409p £250m rights issue (despite 46% discount), underwriters raised another £101m selling leftovers to institutions; 360p price was bottom-end of 360-375p range.
RPC takeover deadline to conclude negotiations with Apollo private equity extended, for a fourth time, to 18 Jan.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
Stock | Code | Close | High | Low |
SHIRE | SHP | 2.7% | 4.6% | 2.7% |
ASTRAZENECA | AZN | -0.7% | 1.8% | -2.1% |
KIER | KIE | -5.6% | -4.8% | -19.2% |
GREENCORE | GNC | 9.3% | 10.1% | 4.3% |
STAGECOACH | SGC | -1.5% | 3.4% | -1.5% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research